LeonaBio (LONA) Change in Accured Expenses (2019 - 2026)

LeonaBio (LONA) has 8 years of Change in Accured Expenses data on file, last reported at -$3.4 million in Q1 2026.

• On a quarterly basis, Change in Accured Expenses rose 56.08% year-over-year to -$3.4 million in Q1 2026; TTM through Mar 2026 was -$17.0 million, a 67.94% decrease from a year earlier, with the FY2025 full-year figure at -$21.3 million, down 271.1% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at -$3.4 million, up from -$11.0 million in the prior quarter.
• Over the last five years, Change in Accured Expenses for LONA reached as high as $6.9 million in Q3 2023 and fell as low as -$11.0 million in Q4 2025.
• Historically, Change in Accured Expenses has averaged -$1.2 million across 5 years, with a median of $164000.0 in 2022.
• Across the five-year window, Change in Accured Expenses soared 1100.17% in 2023 and tumbled 2325.0% in 2024, its largest moves.
• Year by year, Change in Accured Expenses stood at $1.2 million in 2022, then sank by 82.02% to $208000.0 in 2023, then tumbled by 2325.0% to -$4.6 million in 2024, then plunged by 136.73% to -$11.0 million in 2025, then soared by 69.31% to -$3.4 million in 2026.
• Per Business Quant data, the three most recent Change in Accured Expenses figures were -$3.4 million in Q1 2026, -$11.0 million in Q4 2025, and -$207000.0 in Q3 2025.